Solara Active Pharma Sciences Limited has issued a second and final call notice to eligible partly paid rights equity shareholders, marking a crucial step in converting these shares to fully paid status. The company dispatched the notice on April 06, 2026, in electronic mode to shareholders with registered email addresses, while physical copies were sent on April 07, 2026, to those without registered email addresses.

Call Payment Details

The second and final call requires shareholders to pay ₹112.50 per partly paid equity share, structured as follows:

The payment period spans 15 days, providing shareholders with a specific window to complete their obligations:

Payment Methods Available

Shareholders can utilize three distinct payment modes to fulfill their call money obligations:

• Online ASBA: Through Self-Certified Syndicate Banks (SCSBs) websites
• Physical ASBA: By submitting applications to designated SCSB branches
• 3-in-1 Online Accounts: Using linked trading-demat-bank accounts offered by brokers

The company emphasizes that cash payments will not be accepted, and partial payments will be treated as non-payment, potentially leading to share forfeiture.

Rights Issue Background

The current call relates to the company's rights issue executed under a Letter of Offer dated May 09, 2024. Key details of the original rights issue include:

Trading Suspension and Conversion Process

Trading of the ₹7 partly paid equity shares (ISIN: IN9624Z01022) has been suspended on stock exchanges effective April 02, 2026, due to the second and final call. Upon successful payment, the company's Board or authorized committee may convert partly paid shares to fully paid shares in tranches at their discretion.

The conversion process from ₹7 partly paid shares to ₹10 fully paid shares under ISIN INE624Z01016 is estimated to complete within two to three weeks after the Board's conversion decision. However, payments for partly paid shares in a particular demat account will be accepted only once during the payment period.

Consequences of Non-Payment

Shareholders failing to pay the second and final call money face significant consequences. The company reserves the right to deduct outstanding call amounts from future dividends and may forfeit partly paid shares, including amounts already paid, in accordance with the Companies Act, 2013, and the company's Articles of Association.

For queries and clarifications, shareholders can contact the Registrar and Share Transfer Agent, Cameo Corporate Services Limited, at +91 044 40020700 during business hours from Monday to Friday, 9 AM to 5 PM.

Solara Active Pharma Sciences Limited has successfully concluded its Rights Issue Committee meeting and published newspaper advertisements informing shareholders about the second and final call of ₹112.50 per share on partly paid-up equity shares. The pharmaceutical company has set April 2, 2026, as the record date for determining eligible shareholders who must pay the call money.

Committee Meeting Outcomes and Advertisement Publication

Following the Rights Issue Committee meeting held on March 24, 2026, the company published advertisements in Business Standard and Pratahkal newspapers on March 25, 2026. The advertisements inform shareholders about the second and final call and the record date for determining eligible shareholders. These advertisements are also available on the company's website at https://solara.co.in/investor-relations/newspaper-publications .

Trading Suspension and Shareholder Obligations

The company has officially notified that trading in partly paid-up equity shares (ISIN: IN9624201022) will be suspended on stock exchanges with effect from April 1, 2026. Shareholders holding partly paid-up equity shares issued under the rights offering must pay the final call amount of ₹112.50 per share to convert these into fully paid-up equity shares. Call notices will be dispatched to eligible shareholders for payment of the call amount.

Share Transfer Re-lodgement Window

The company has also announced a re-lodgement window for physical share transfer requests that were previously rejected. Shareholders can re-lodge transfer requests from February 5, 2024, to February 4, 2027, for transfers that were rejected before April 1, 2019, or those lodged before April 1, 2019, but rejected due to document deficiencies. The re-lodged securities will be transferred only in demat mode once all documents are verified by the Registrar and Transfer Agent, Cameo Corporate Services Limited.

Regulatory Compliance and Documentation

Company Secretary and Compliance Officer Pooja Jaya Kumar has signed all official communications to stock exchanges, ensuring proper regulatory disclosure under SEBI Listing Regulations. The company maintains full compliance with Regulation 30 and 42 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, throughout the rights issue process. The comprehensive documentation includes the original Letter of Offer dated May 9, 2024, and all subsequent regulatory filings related to the rights issue completion.